MedPath

EpiRetinal Membrane Peeling and Internal Limiting Membrane

Terminated
Conditions
Macular Pucker
Internal Limiting Membrane
Epiretinal Membrane
Interventions
Procedure: Epiretinal membrane surgery
Registration Number
NCT04802265
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

To study and compare visual acuity in patients undergoing removal of the epiretinal membrane with and without the removal of the internal limiting membrane at baseline versus 6 month.

Detailed Description

This prospective cohort study includes 2 arms : with and without internal limiting membrane (ILM) peeling.

Each patient undergo the same procedure : first of all pars plana vitrectomy, then internal limiting membrane peeling is performed and facilitated by the use of dye, which aids in better visualization of the ILM.

If the ILM is removed in same time : the patient is ranked in the "ILM peeling" group If the ILM is not removed : the patient is ranked in the "non ILM peeling" group.

If the ILM is partially removed, the patient is not enrolled.

The outcomes are recorded for 6 months : at baseline, day 15, 1, 3 and 6 months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • adult up to 18 years old,
  • diagnosed and treated surgically
Exclusion Criteria
  • proliferative diabetic retinopathy,
  • ocular trauma,
  • central veinous occlusion,
  • intra-ocular tumor, total retinal detachment,
  • central visual field loss in glaucomatous patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
without ILM peelingEpiretinal membrane surgeryILM is not peeled during epiretinal membrane surgery
ILM peelingEpiretinal membrane surgeryILM is peeled during epiretinal membrane surgery
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity (BCVA) (metric : LogMAR)Day 180

BCVA is measured at each medical appointment. Monoyer Scale is used and results are converted in LogMAR scale.

Secondary Outcome Measures
NameTimeMethod
near visual acuity measured at baseline, day 15, 1, 3 and 6 monthDay 180

near visual acuity is measured at each medical appointment using Parinaud Scale

central retinal thickness (CRT)Day 180

CRT is measured on optical coherence tomography (OCT) at baseline, day 15, 1 , 3 and 6 months

peeling initiation retinal thicknessDay 180

to evaluate the damage due to the membrane gripping during the peeling initiation, retinal thickness is performed at this location by OCT.

10° visual fieldDay 180

a 10° Visual Field is performed at baseline, 1 month and 6 month

BCVA at day 15, 1, 3 month.Day 15, Day 30, Day 90

BCVA is measured at each medical appointment. Monoyer Scale is used and. Resulats are converted in LogMAR scale.

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, Aura, France

© Copyright 2025. All Rights Reserved by MedPath